Serum IL-27 levels were significantly decreased in NSCLC patients (241.74 ± 38.13 pg/mL) as compared to normal controls (318.13 ± 16.38 pg/mL, P < 0.0001) (Figure 1(a)). Here, IL27 is linked to non-small cell lung carcinoma.